Enabling AI for Rare Disease Patients | TMA Precision CEO Joshua Resnikoff

We’re joined by Joshua, CEO of TMA Precision Health, to explore their innovative approach to tackling the diagnostic odyssey for rare disease patients through tech-enabled solutions and AI-driven insights.TMA Precision Health is revolutionizing rare disease care by reducing the diagnostic timeline from seven years to just a few months, addressing gaps in accessibility and healthcare equity. Joshua shares his journey from research at Harvard to founding TMA, his personal connection to rare disease through his son, and the company’s mission to democratize healthcare. Discover how TMA leverages precision medicine, whole genome sequencing, and AI to create a scalable, patient-centric system that bridges the gap between innovation and care.